Histopathological study of the protective effects of ethanolic extract of Crocus sativus L. (Saffron) stigma on hepatic and renal tissue changes in alloxanized diabetic rats

Subject Areas : Veterinary Clinical Pathology

داریوش Mohajeri ¹ , مهران Mesgari ² , Gh Mousavi ³ , یوسف Doustar ⁴ , بهرام Amouoghli Tabrizi ⁵

1 - Department of Pathobiology, Faculty of Veterinary Medicine, Islamic Azad University, Tabriz Branch, Tabriz, Iran
2 - Drug Applied Research Center, Tabriz University of Medical Science, Tabriz, Iran
3 - Department of Clinical Sciences, Faculty of Veterinary Medicine, Islamic Azad University, Tabriz Branch, Tabriz, Iran
4 - Department of Pathobiology, Faculty of Veterinary Medicine, Islamic Azad University, Tabriz Branch, Tabriz, Iran
5 - Department of Clinical Sciences, Faculty of Veterinary Medicine, Islamic Azad University, Tabriz Branch, Tabriz, Iran

Received: 2008-10-29 Accepted : 2009-01-19 Published : 2008-08-22

Keywords: Diabetes, Alloxan, Crocus sativus L, stigma, ethanolic extract, histopathology,

Abstract :

Diabetes mellitus is a metabolic disorder affecting mankind and its incidence is considered to be high all over the world. Hepatic and renal insufficiencies are identified as the most important causes of death in this disease. A multitude of herbs has been described for the treatment of diabetics throughout the world. The aim of the present study was to assess the protective effects of ethanolic saffron stigma extract (Crocus sativus L.) on early hepatic and renal injuries in alloxan-induced diabetic rats.  For this purpose, 72 male wistar rats were randomly assigned to six different groups of 12 rats each, including healthy control rats, healthy control rats receiving ethanolic saffron extract, mild diabetic (MD) rats, mild diabetic rats receiving ethanolic saffron extract, severely diabetic (SD) rats and severely diabetic rats receiving ethanolic saffron extract. The most effective dose of the extract in reducing blood glucose (40 mg/kg), dissolved in normal saline solution (10 ml/kg) was administered intraperitoneally to treatment groups receiving the extract for 30 consecutive days. Control groups received normal saline solution in the same manner. Four hours after the last extract injections, all rats were euthanized simultaneously by cervical dislocation. Tissue specimens were fixed in 10% buffered formalin and 5 micron thick sections were prepared using routine hitopathological techniques. Histopathology of the liver and kidney in diabetic rats showed a spectrum of changes including periportal degeneration, membranoproliferative glomerulitis, enlargement of lining cells of tubules, lymphocytic infiltration, hyperemia and hemorrhage. These injuries were more prominent in SD rats. The histopathological appearance of liver and kidneys in ethanolic extract treated diabetic rats was near normal. The findings of the present study indicate that ethanolic extract of Crocus sativus L. stigma has protective effects on early diabetic nephropathy and hepatopathy in experimentally induced diabetes. Therefore, ethanolic extract of Crocus sativus L. stigma is recommended for prevention of early renal and hepatic injuries in diabetes mellitus, after randomized clinical trials.

References:

1. ابراهیم زاده، ح.، رجبیان، ط.، ابریشم‌چی، پ.، کرمیان، ر. و صبورا ع. (1385): زعفران ایران با نگاه پژوهشی، چاپ اول، انتشارات اطلاعات،  صفحات: 591-587.

1. کافی، م. (1381): زعفران: فنآوری تولید و فرآوری، چاپ اول، انتشارات دانشگاه فردوسی مشهد، صفحات: 135-21 و 275-209.
   
   
   1. Abdullaev, F.I. (2002): Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp. Biol. Med., 227(1): 20-25.
   
   
   2. Abe, K. and Saito, H. (2000): Effects of saffron and its constituent crocin on learning behavior and long-term potentiation. Phytother. Res., 14(3): 149-152.
   
   
   3. Akhtar, M.S. and Iqbal, J. (1991): Evaluation of the hypoglycemic effect of Achyranthes aspera in normal and alloxan diabetic rabbits. J. Ethnopharmacol.,31(1): 49-57.
   
   
   4. Assimopoulou, A.N., Sinakos, Z. and Papageorgiou, V.P. (2005): Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother. Res., 19(11): 997-1000.
   
   
   5. Bailey, L.J. and Day, C. (1989): Traditional plant medicine as treatment for diabetes. Diabetes Care, 12(8): 553-564.
   
   
   6. Cameron, N.E., Gibson, T.M., Nangle, M.R. and Cotter, M.A. (2005): Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Annual New York Academic Science, 1043: 784–792.
   
   
   7. Davis, S.N. and Granner, D.K. (2001): Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas, Goodman Gilman's The Pharmacological Basis of Therapeutics. 10th ed., The McGraw-Hill Companies Inc., USA, pp: 1690.
   
   
   8. Duke, J.A. (2000): Crocus sativus L. (Iridaceae)-Saffron. Saffron crocus. Handbook of Medicinal Herbs. pp: 148-149.
   
   
   9. El Daly, E.S. (1998): Protective effect of cysteine and vitamin E, Croucus sativus and Nigella sativa Extracts on cisplatin-induced toxicity in rats. J. Pharm. Belg., 53(2): 87-95.
   
   
   10. Giaccio, M. (2004): Crocetin from saffron: An active component of an ancient spice. Crit. Rev. Food Sci. Nutr., 44(3): 155-172.
   
   
   11. Gupta, R.K., Kesari, A.N., Murthy, P.S., Chandra, R., Tandon, V. and Watal, G. (2005): Hypoglycemic and antidiabetic effect of ethanolic extract of leaves of Annona squamosa L. in experimental animals. J. Ethnopharmacol., 99(1): 75-81.
   
   
   12. Holman, R.R. and Turner, R.C. Oral agents and insulin in the treatment of NIDDM. In: Pickup, J. and Wiliams, G. (1991): Textbook of Diabetes. Blackwell, Oxford, pp: 407–469.
   
   
   13. Hosseinzadeh, H., Sadeghnia, H.R., Ziaee, T. and Danaee, A. (2005): Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats. J. Pharm. Pharm. Sci.,8(3): 387-93.
   
   
   14. Ivorra, M.D., Paya, M. and Villar, A. (1989): A review of natural products and plants as potential antidiabetic drugs. J. Ethnopharmacol., 27(3): 243-275.
   
   
   15. Jandeleit-Dahm, K.A., Lassila, M. and Allen, T.J. (2005): Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies. Annual New York Academic Science, 1043: 759–766.
   
   
   16. Kalia, K., Sharma, S. and Mistry, K. (2004): Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy. Clinical & Chemical Acta, 347: 169–176.
   
   
   17. Kesari, A.N., Gupta, R.K. and Watal, G. (2005): Hypoglycemic effects of Murraya koenigii on normal and alloxan diabetic rabbits. J. Ethnopharmacol., 97(2): 247-251.
   
   
   18. Kesari, A.N., Gupta, R.K., Singh, S.K., Diwakar, S. and Watal, G. (2006): Hypoglycemic and antihyperglycemic activity of Aegle marmelos seed extract in normal and diabetic rats. J. Ethnopharmacol., 107(3): 374-379.
   
   
   19. Kotajima, N., Kimura, T., Kanda, T., Obata, K., Kuwabara, A., Fukumura, Y. and Kobayashi, I. (2000): Type IV collagen as an early marker for diabetic nephropathy in non-insulin-dependent diabetes mellitus. Journal of Diabetes Complication, 14: 13–17.
   
   
   20. Larner, J. Insulin and oral hypoglycemic drugs; Glucagon. In: Gilman, A.G. Goodman, L.S. Rall, T.W. and Murad, F. (1985): The Pharmacolgical Bases for Therapeutic. 7^th ed., Macmillan, New York, pp: 149–151.
   
   
   21. Liu, H.R., Tang, X.Y., Dai, D.Z. and Dai, Y. (2008): Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats. Journal of Ethnopharmacology,  118(3): 466-472.
   
   
   22. Luo, J., Fort, D.M., Carlson, T.J., Noamesi, B.K., nii-Amon-Kotei, D., King, S.R., Tsai, J., Quan, J., et al. (1998): Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent. Diabet. Med., 15(5): 367-374.
   
   
   23. Marles, R.J. and Farnsworth, N.R. (1995): Antidiabetic plants and their active constituents. Phytomedicine, 2(2): 137–189.
   
   
   24. Midwood, K.S., Williams, L.V. and Schwarzbauer, J.E. (2004): Tissue repair and the dynamics of the extracellular matrix. International Journal of Biochemistry & Cell Biology, 36: 1031–1037.
   
   
   25. Mohajeri, D., Amouoghli Tabrizi, B., Mousavi, Gh. and Mesgari, M. (2008): Anti-diabetic activity of Crocus sativus L. (Saffron) stigma ethanolic extract in alloxan-induced diabetic rats. Research of Biological Science, 3(9): 1102-1108.
   
   
   26. Pickup, J.C. and William, G. (1997): Epidemiology of diabetes mellitus. Textbook of Diabetes, vol. I, 2^nd ed., Blackwell, Oxford, pp: 3.1–3.28.
   
   
   27. Ríos, J.L., Recio, M.C., Giner, R.M. and Máñez, S. (1996): An update review of saffron and its active constituents. Phytother. Res., 10(3): 189-193.
   
   
   28. Sharma, S.R., Dwivedi, S.K., Varshney, V.P. and Swarup, D. (1996): Antihyperglycemic and Insulin release effects of Aegle marmelos leaves in streptozotocin-diabetic rats. Phytother. Res., 10(5): 426–428.
   
   
   29. Sharma, S.R., Dwivedi, S.K. and Swarup, D. (1996): Hypoglycaemic and hypolipidemic effects of Cinnamomum tamala Nees leaves. Indian J. Exp. Biol., 34(4): 372-374.
   
   
   30. Sharma, S.B., Nasir, A., Prabhu, K.M., Murthy, P.S. and Dev, G. (2003): Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. Journal of Ethnopharmacology, 85(2-3): 201-206.
   
   
   31. Soeda, S., Ochiai, T., Paopong, L., Tanaka, H., Shoyama, Y. and Shimeno, H. (2001): Crocin suppresses tumor necrosis factor alpha-induced cell death of neuronally differentiated PC-12 cells. Life Sci., 69(24): 2887-98.
   
   
   32. Sottile, J. (2004): Regulation of angiogenesis by extracellular matrix.  Biochemistry & Biophysics Acta, 1654: 13–22.
   
   
   33. Vestra, M.D. and Fioretto, P. (2003): Diabetic nephropathy: renal structural studies in type 1 and type 2 diabetic patients. Internatrional Congress Series, 1253: 163–169.
   
   
   34. Vural, P., Cevik, A., Curgunlu, A. and Canbaz, M. (2002): Effects of diabetes mellitus and acute hypertension on plasma nitricoxide and endothelin concentrations in rats. Clinical & Chemical Acta, 320: 43–47.
   
   
   35. Welihinda, J. and Karunanayake, E.H. (1986): Extra pancreatic effect of M. charantia in rats. Journal of Ethanopharmacology, 173: 247–255.
   
   
   36. WHO. (1980): Expert committee on Diabetes mellitus, Technical reports series World Health Organization, Geneva.
   
   
   37. Yamanea, T. Yamaguchib, N., Yoshidaa Y. and Mitsumatac, M. (2004):  Regulation of extracellular matrix production and degradation of endothelial cells by shear stress. International Congress Series, 1262: 407–410.